Correlation between 25-hydroxy-vitamin D and Parkinson's disease

Background: Previous cross-sectional studies have shown that Parkinson’s disease (PD) patients have lower serum 25-hydroxyvitamin D (25(OH)D) concentrations than controls. Other studies have not yet tested whether research findings from other regions are generalizable to Chinese populations. In this...

Full description

Bibliographic Details
Main Authors: Ming Xia, Qingjiu Zhou
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:IBRO Neuroscience Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667242123000167
_version_ 1797341465561530368
author Ming Xia
Qingjiu Zhou
author_facet Ming Xia
Qingjiu Zhou
author_sort Ming Xia
collection DOAJ
description Background: Previous cross-sectional studies have shown that Parkinson’s disease (PD) patients have lower serum 25-hydroxyvitamin D (25(OH)D) concentrations than controls. Other studies have not yet tested whether research findings from other regions are generalizable to Chinese populations. In this case-control study, we examined the correlation between 25-hydroxyvitamin D and Parkinson's disease. Methods: We established an association between 25-hydroxyvitamin D deficiency and PD in a case-control study of 100 PD patients and 100 control subjects free of neurological disease at the First Affiliated Hospital of Xinjiang Medical University. Results: Total 25-hydroxyvitamin D levels were deficient in 21 % of patients with PD compared with 4 % of controls. In univariate analyses, plasma levels of 25-hydroxyvitamin D were associated with PD (p < 0.001). In multivariate analyses, vitamin D deficiency (25(OH)D < 20 ng/mL) was significantly associated with PD (p = 0.008, Odds Ratio =17.13, 95 % CI= 2.082–141.075). Individuals with 25(OH)D levels in the lowest quartile had the highest prevalence of PD (p = 0.026, OR=11.786, 95 % CI =1.342–103.51 compared to individuals with values in the highest quartile). Conclusions: Our study reveals an association between 25-hydroxyvitamin D and PD. Patients with incident PD had significantly lower serum 25(OH)D concentrations than age-matched controls. High-risk PD patients with vitamin D deficiency who have not yet developed exercise impairment should undergo vitamin D measurement and any necessary treatment as soon as possible. Limitations of the study: the study needs further assessment of populations with low vitamin D levels in other regions of China; further assessment of the effect of different sources of vitamin D on PD; further study of longitudinal cohorts at different time points.
first_indexed 2024-03-08T10:18:32Z
format Article
id doaj.art-3381bb126491456abd45f11ccf952cb6
institution Directory Open Access Journal
issn 2667-2421
language English
last_indexed 2024-03-08T10:18:32Z
publishDate 2024-06-01
publisher Elsevier
record_format Article
series IBRO Neuroscience Reports
spelling doaj.art-3381bb126491456abd45f11ccf952cb62024-01-28T04:21:55ZengElsevierIBRO Neuroscience Reports2667-24212024-06-0116162167Correlation between 25-hydroxy-vitamin D and Parkinson's diseaseMing Xia0Qingjiu Zhou1Department of Neurosurgery, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, ChinaCorrespondence to: Department of Neurosurgery, First Affiliated Hospital of Xinjiang Medical University, No. 137, Liyushan Road, Urumqi, China.; Department of Neurosurgery, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, ChinaBackground: Previous cross-sectional studies have shown that Parkinson’s disease (PD) patients have lower serum 25-hydroxyvitamin D (25(OH)D) concentrations than controls. Other studies have not yet tested whether research findings from other regions are generalizable to Chinese populations. In this case-control study, we examined the correlation between 25-hydroxyvitamin D and Parkinson's disease. Methods: We established an association between 25-hydroxyvitamin D deficiency and PD in a case-control study of 100 PD patients and 100 control subjects free of neurological disease at the First Affiliated Hospital of Xinjiang Medical University. Results: Total 25-hydroxyvitamin D levels were deficient in 21 % of patients with PD compared with 4 % of controls. In univariate analyses, plasma levels of 25-hydroxyvitamin D were associated with PD (p < 0.001). In multivariate analyses, vitamin D deficiency (25(OH)D < 20 ng/mL) was significantly associated with PD (p = 0.008, Odds Ratio =17.13, 95 % CI= 2.082–141.075). Individuals with 25(OH)D levels in the lowest quartile had the highest prevalence of PD (p = 0.026, OR=11.786, 95 % CI =1.342–103.51 compared to individuals with values in the highest quartile). Conclusions: Our study reveals an association between 25-hydroxyvitamin D and PD. Patients with incident PD had significantly lower serum 25(OH)D concentrations than age-matched controls. High-risk PD patients with vitamin D deficiency who have not yet developed exercise impairment should undergo vitamin D measurement and any necessary treatment as soon as possible. Limitations of the study: the study needs further assessment of populations with low vitamin D levels in other regions of China; further assessment of the effect of different sources of vitamin D on PD; further study of longitudinal cohorts at different time points.http://www.sciencedirect.com/science/article/pii/S2667242123000167Vitamin DParkinson’s disease25-hydroxy vitamin DSunshineHoehn and Yahr stage
spellingShingle Ming Xia
Qingjiu Zhou
Correlation between 25-hydroxy-vitamin D and Parkinson's disease
IBRO Neuroscience Reports
Vitamin D
Parkinson’s disease
25-hydroxy vitamin D
Sunshine
Hoehn and Yahr stage
title Correlation between 25-hydroxy-vitamin D and Parkinson's disease
title_full Correlation between 25-hydroxy-vitamin D and Parkinson's disease
title_fullStr Correlation between 25-hydroxy-vitamin D and Parkinson's disease
title_full_unstemmed Correlation between 25-hydroxy-vitamin D and Parkinson's disease
title_short Correlation between 25-hydroxy-vitamin D and Parkinson's disease
title_sort correlation between 25 hydroxy vitamin d and parkinson s disease
topic Vitamin D
Parkinson’s disease
25-hydroxy vitamin D
Sunshine
Hoehn and Yahr stage
url http://www.sciencedirect.com/science/article/pii/S2667242123000167
work_keys_str_mv AT mingxia correlationbetween25hydroxyvitamindandparkinsonsdisease
AT qingjiuzhou correlationbetween25hydroxyvitamindandparkinsonsdisease